Pharma tycoon's Divis Laboratories gets 90 percent of its $425 million annual revenues from overseas, exporting 100 products from two factories in south India, both approved by the US Food and Drug Administration. Half of its business is from custom manufacturing for big pharma companies, the remainder from generics.
Fast Fact: A fitness fanatic, he has built a yoga centre at Divis's headquarters in Hyderabad.